Common Contracts
7 similar Sales Agreement contracts by Tenax Therapeutics, Inc., Unity Biotechnology, Inc., Allogene Therapeutics, Inc., others
ALLOGENE THERAPEUTICS, INC. Shares of Common Stock ($0.001 par value) AMENDMENT NO. 1 TO THE SALES AGREEMENTSales Agreement • November 2nd, 2022 • Allogene Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Reference is made to the Sales Agreement, dated November 5, 2019 (the “Agreement”), by and between Allogene Therapeutics, Inc., a Delaware corporation (the “Company”), and Cowen and Company, LLC (the “Agent”). The Company and the Agent (collectively, the “Parties”) wish to amend the Agreement, pursuant to Section 15 of the Agreement, to allow for the issuance and sale of Placement Shares under the Agreement pursuant to a new Registration Statement (as defined below) (this “Amendment”). The Parties therefore hereby agree as follows:
unity biotechnology, inc. $50,000,000 shares of common stock SALES AGREEMENTSales Agreement • March 15th, 2022 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
Unity Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
GLYCOMIMETICS, INC. Common Stock (par value $0.001 per share) SALES AGREEMENTSales Agreement • October 7th, 2020 • Glycomimetics Inc • Pharmaceutical preparations • New York
GlycoMimetics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
unity biotechnology, inc. $50,000,000 shares of common stock SALES AGREEMENTSales Agreement • July 31st, 2020 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
Unity Biotechnology, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
TRILLIUM THERAPEUTICS INC. $25,000,000 Common Shares SALES AGREEMENTSales Agreement • June 20th, 2018 • Trillium Therapeutics Inc. • Pharmaceutical preparations • New York
Trillium Therapeutics Inc., a corporation organized under the laws of the Province of Ontario, Canada (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
TENAX THERAPEUTICS, INC. SALES AGREEMENTSales Agreement • July 14th, 2015 • Tenax Therapeutics, Inc. • Services-commercial physical & biological research • New York
TENAX THERAPEUTICS, INC. SALES AGREEMENTSales Agreement • February 24th, 2015 • Tenax Therapeutics, Inc. • Services-commercial physical & biological research • New York
